Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 162 results.
User Information
Export Records
  1. 1.   CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytes
  2. Brault, Julie; Liu, Taylor; Bello, Ezekiel; Liu, Siyuan; Sweeney, Colin L.; Meis, Ronald J.; Koontz, Sherry; Corsino, Cristina; Choi, Uimook; Vayssiere, Guillaume; Bosticardo, Marita; Dowdell, Kennichi; Lazzarotto, Cicera R.; Clark, Aaron B.; Notarangelo, Luigi D.; Ravell, Juan C.; Lenardo, Michael J.; Kleinstiver, Benjamin P.; Tsai, Shengdar Q.; Wu, Xiaolin; Dahl, Gary A.; Malech, Harry L.; De Ravin, Suk See
  3. Blood. 2021, Dec 30; 138(26): 2768-2780.
  1. 2.   IL-21 and IFN alpha therapy rescues terminally differentiated NK cells and limits SIV reservoir in ART-treated macaques
  2. Harper, Justin; Huot, Nicolas; Micci, Luca; Tharp, Gregory; King, Colin; Rascle, Philippe; Shenvi, Neeta; Wang, Hong; Galardi, Cristin; Upadhyay, Amit A.; Villinger, Francois; Lifson,Jeffrey; Silvestri, Guido; Easley, Kirk; Jacquelin, Beatrice; Bosinger, Steven; Muller-Trutwin, Michaela; Paiardini, Mirko
  3. Nature communications. 2021, May 17; 12(1):
  1. 3.   Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
  2. Davar, Diwakar; Dzutsev, Amiran K.; McCulloch, John A.; Rodrigues,Richard; Chauvin, Joe-Marc; Morrison, Robert M.; Deblasio, Richelle N.; Menna, Carmine; Ding, Quanquan; Pagliano, Ornella; Zidi, Bochra; Zhang, Shuowen; Badger, Jonathan H.; Vetizou, Marie; Cole, Alicia M.; Fernandes, Miriam R.; Prescott, Stephanie; Costa, Raquel G. F.; Balaji, Ascharya K.; Morgun, Andrey; Vujkovic-Cvijin, Ivan; Wang, Hong; Borhani, Amir A.; Schwartz, Marc B.; Dubner, Howard M.; Ernst, Scarlett J.; Rose, Amy; Najjar, Yana G.; Belkaid, Yasmine; Kirkwood, John M.; Trinchieri,Giorgio; Zarour, Hassane M.
  3. Science. 2021, Feb 5; 371(6529): 595-602.
  1. 4.   Ascorbic Acid Promotes KIR Demethylation during Early NK Cell Differentiation
  2. Wu, Cheng-Ying; Zhang, Bin; Kim, Hansol; Anderson,Steve; Miller, Jeffrey S; Cichocki, Frank
  3. Journal of immunology (Baltimore, Md. : 1950). 2020, SEP 15; 205(6): 1513-1523.
  1. 5.   Minimal PD-1 expression in mouse and human NK cells under diverse conditions
  2. Judge, Sean J.; Dunai, Cordelia; Aguilar, Ethan G.; Vick, Sarah C.; Sturgill, Ian R.; Khuat, Lam T.; Stoffel, Kevin M.; Van Dyke, Jonathan; Longo, Dan L.; Darrow, Morgan A.; Anderson,Steve; Blazar, Bruce R.; Monjazeb, Arta M.; Serody, Jonathan S.; Canter, Robert J.; Murphy, William J.
  3. JOURNAL OF CLINICAL INVESTIGATION. 2020, JUN 1; 130(6): 3051-3068.
  1. 6.   Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-?, CXCL9 and CXCL10
  2. Bergamaschi,Cristina; Pandit,Hrishikesh; Nagy,Bethany; Stellas,Dimitris; Jensen, Shawn M; Bear,Jenifer; Cam,Maggie; Valentin,Antonio; Fox, Bernard A; Felber,Barbara; Pavlakis,George
  3. Journal for immunotherapy of cancer. 2020, May; 8(1): e000599.
  1. 7.   IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
  2. Conlon, Kevin C.; Potter, E. Lake; Pittaluga, Stefania; Lee, Chyi-Chia Richard; Miljkovic, Milos D.; Fleisher, Thomas A.; Dubois, Sigrid; Bryant, Bonita R.; Petrus, Michael; Perera, Liyanage P.; Hsu, Jennifer; Figg, William D.; Peer, Cody J.; Shih, Joanna H.; Yovandich,Jason; Creekmore,Stephen; Roederer, Mario; Waldmann, Thomas A.
  3. CLINICAL CANCER RESEARCH. 2019, Aug 15; 25(16): 4945-4954.
  1. 8.   Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective
  2. Basudhar,Debashree; Bharadwaj, Gaurav; Somasundaram,Veena; Cheng,Robert; Ridnour,Lisa; Fujita, Mayumi; Lockett,Stephen; Anderson,Steve; McVicar,Daniel; Wink,David
  3. British Journal of Pharmacology. 2019, Jan; 176(2): 155-176.
  1. 9.   HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C*12:02/C*14:03
  2. Lin, Zhansong; Kuroki, Kimiko; Kuse, Nozomi; Sun, Xiaoming; Akahoshi, Tomohiro; Qi, Ying; Chikata, Takayuki; Naruto, Takuya; Koyanagi, Madoka; Murakoshi, Hayato; Gatanaga, Hiroyuki; Oka, Shinichi; Carrington, Mary; Maenaka, Katsumi; Takiguchi, Masafumi
  3. CELL REPORTS. 2016, Nov 22; 17(9): 2210-2220.
  1. 10.   Diversity of the KIR gene cluster in an urban Brazilian population
  2. Augusto, D. G.; Zehnder-Alves, L.; Pincerati, M. R.; Martin, M. P.; Carrington, M.; Petzl-Erler, M. L.
  3. Immunogenetics. 2012, Feb; 64(2): 143-152.
  1. 11.   Altered distribution of mucosal NK cells during HIV infection
  2. Sips, M.; Sciaranghella, G.; Diefenbach, T.; Dugast, A. S.; Berger, C. T.; Liu, Q.; Kwon, D.; Ghebremichael, M.; Estes, J. D.; Carrington, M.; Martin, J. N.; Deeks, S. G.; Hunt, P. W.; Alter, G.
  3. Mucosal Immunology. 2012, Jan; 5(1): 30-40.
  1. 12.   Copy Number Variation of KIR Genes Influences HIV-1 Control
  2. Pelak, K.; Need, A. C.; Fellay, J.; Shianna, K. V.; Feng, S.; Urban, T. J.; Ge, D. L.; De Luca, A.; Martinez-Picado, J.; Wolinsky, S. M.; Martinson, J. J.; Jamieson, B. D.; Bream, J. H.; Martin, M. P.; Borrow, P.; Letvin, N. L.; McMichael, A. J.; Haynes, B. F.; Telenti, A.; Carrington, M.; Goldstein, D. B.; Alter, G.; Vaccine, N. C. H. A.
  3. Plos Biology. 2011, Nov; 9(11):
  1. 13.   The split personality of NKT cells in malignancy, autoimmune and allergic disorders
  2. Subleski, J. J.; Jiang, Q.; Weiss, J. M.; Wiltrout, R. H.
  3. Immunotherapy. 2011, Oct; 3(10): 1167-1184.
  1. 14.   KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection
  2. al Basatena, N. K. S.; MacNamara, A.; Vine, A. M.; Thio, C. L.; Astemborski, J.; Usuku, K.; Osame, M.; Kirk, G. D.; Donfield, S. M.; Goedert, J. J.; Bangham, C. R. M.; Carrington, M.; Khakoo, S. I.; Asquith, B.
  3. Plos Pathogens. 2011, Oct; 7(10): 12.
  1. 15.   Ex vivo functional responses to HLA-G differ between blood and decidual NK cells
  2. Apps, R.; Sharkey, A.; Gardner, L.; Male, V.; Kennedy, P.; Masters, L.; Farrell, L.; Jones, D.; Thomas, R.; Moffett, A.
  3. Molecular Human Reproduction. 2011, Sep; 17(9): 577-586.
  1. 16.   HIV-1 adaptation to NK-cell-mediated immune pressure
  2. Alter, G.; Heckerman, D.; Schneidewind, A.; Fadda, L.; Kadie, C. M.; Carlson, J. M.; Oniangue-Ndza, C.; Martin, M.; Li, B.; Khakoo, S. I.; Carrington, M.; Allen, T. M.; Altfeld, M.
  3. Nature. 2011, Aug; 476(7358): 96-+.
  1. 17.   mTOR Kinase Inhibitor AZD8055 Enhances the Immunotherapeutic Activity of an Agonist CD40 Antibody in Cancer Treatment
  2. Jiang, Q.; Weiss, J. M.; Back, T.; Chan, T.; Ortaldo, J. R.; Guichard, S.; Wiltrout, R. H.
  3. Cancer Research. 2011, Jun; 71(12): 4074-4084.
  1. 18.   Mouse Ly49G2(+) NK cells dominate early responses during both immune reconstitution and activation independently of MHC
  2. Barao, I.; Alvarez, M.; Ames, E.; Orr, M. T.; Stefanski, H. E.; Blazar, B. R.; Lanier, L. L.; Anderson, S. K.; Redelman, D.; Murphy, W. J.
  3. Blood. 2011, Jun; 117(26): 7032-7041.
  1. 19.   Killer Immunoglobulin-Like Receptor Transcriptional Regulation: A Fascinating Dance of Multiple Promoters
  2. Cichocki, F.; Miller, J. S.; Anderson, S. K.
  3. Journal of Innate Immunity. 2011, Apr; 3(3): 242-248.
  1. 20.   KIR Polymorphisms Modulate Peptide-Dependent Binding to an MHC Class I Ligand with a Bw6 Motif
  2. Colantonio, A. D.; Bimber, B. N.; Neidermyer, W. J.; Reeves, R. K.; Alter, G.; Altfeld, M.; Johnson, R. P.; Carrington, M.; O'Connor, D. H.; Evans, D. T.
  3. Plos Pathogens. 2011, Mar; 7(3): 13.
  1. 21.   LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes?
  2. Orr, S. J.; McVicar, D. W.
  3. Journal of Leukocyte Biology. 2011, Jan; 89(1): 11-19.
  1. 22.   TCR-Dependent and -Independent Activation Underlie Liver-Specific Regulation of NKT Cells
  2. Subleski, J. J.; Hall, V. L.; Wolfe, T. B.; Scarzello, A. J.; Weiss, J. M.; Chan, T.; Hodge, D. L.; Back, T. C.; Ortaldo, J. R.; Wiltrout, R. H.
  3. Journal of Immunology. 2011, Jan; 186(2): 838-847.
  1. 23.   HLA/KIR Restraint of HIV: Surviving the Fittest
  2. Bashirova, A. A.; Thomas, R.; Carrington, M.; Paul, W. E.; Littman, D. R.; Yokoyama, W. M.
  3. Annual Review of Immunology. 2011 29: 295-317.
  1. 24.   Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model
  2. Yu, P.; Steel, J. C.; Zhang, M. L.; Morris, J. C.; Waldmann, T. A.
  3. Clinical Cancer Research. 2010, Dec; 16(24): 6019-6028.
  1. 25.   Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
  2. Shurin, M. R.; Gregory, M.; Morris, J. C.; Malyguine, A. M.
  3. Expert Opinion on Biological Therapy. 2010, Nov; 10(11): 1539-1553.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel